COMPANY

Progentec Diagnostics

HQ: Oklahoma City, OK source · progentec.com ↗ · Southwest

Also known as PROGENTEC DIAGNOSTICS INC · 8 sources

Location: Oklahoma City, OK · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Systemic Lupus Erythematosus Lupus Erythematosus SLE Lupus Flare

Funding and NIH signals

NIH award NIH awarded $895K (SBIR commercialization 5SB1AI184309-03, continuation, notice Jun 12, 2026). NIH RePORTER 5SB1AI184309-03 (Jun 12, 2026)
Evidence (1 event)
- Jun 12, 2026 · NIH RePORTER 5SB1AI184309-03
  Organization: PROGENTEC DIAGNOSTICS, INC.; City/State: Oklahoma City, OK; Project number: 5SB1AI184309-03; Activity code: SB1; Fiscal year: 2026; Award notice date: 2026-06-12; FY total cost (award amount): 895140; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Commercialization Readiness of Immune Mediator Based Blood Tests that Inform Concurrent and Future Clinical Disease Activity in Systemic Lupus Erythematosus (SLE); Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Jun 12, 2026 Grant Government grant — SBIR: $895,140 (annual award, as published), announced Jun 12, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 28, 2025 Grant Government grant — SBIR: $895,140 (annual award, as published), announced Apr 28, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 28, 2020 Trial start —: Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals source ↗
May 31, 2019 Trial start —: Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic source ↗

Last 2 years.

Jun 12, 2026 Government grant — SBIR: $895,140 (annual award, as published), announced Jun 12, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 28, 2025 Government grant — SBIR: $895,140 (annual award, as published), announced Apr 28, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT04018222	Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic	Not listed	Unknown status (ClinicalTrials.gov)	May 31, 2019	Dec 31, 2020 (estimated)
NCT04449653	Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals	Not listed	Unknown status (ClinicalTrials.gov)	Apr 28, 2020	Dec 31, 2020 (estimated)

Annual award amounts. Total $2.6M.

Jun 25, 2024 NIH award 1SB1AI184309-01 FY2024: $895,140 awarded for that fiscal year; activity SB1 (SBIR); PI MUNROE, MELISSA E; recipient as written: PROGENTEC DIAGNOSTICS, INC., Oklahoma City, OK. Commercialization Readiness of source ↗
Apr 30, 2021 NIH award 5R44AI142967-03 FY2021: $742,933 awarded for that fiscal year; activity R44 (SBIR); PI MUNROE, MELISSA E; recipient as written: PROGENTEC DIAGNOSTICS, INC., Oklahoma City, OK. Development of Immune Mediator source ↗
Apr 24, 2020 NIH award 4R44AI142967-02 FY2020: $742,933 awarded for that fiscal year; activity R44 (SBIR); PI MUNROE, MELISSA E; recipient as written: PROGENTEC DIAGNOSTICS, INC., Oklahoma City, OK. Development of Immune Mediator source ↗
Jul 17, 2019 NIH award 1R44AI142967-01A1 FY2019: $225,000 awarded for that fiscal year; activity R44 (SBIR); PI MUNROE, MELISSA E; recipient as written: PROGENTEC DIAGNOSTICS, INC., Oklahoma City, OK. Development of Immune Mediat source ↗